Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 10.09.2026 | Verkauf | 17,62 | 10.185 | 179.457 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 10.09.2026 | Optionsausübung | 8,04 | 10.185 | 81.887 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 28.08.2026 | Verkauf | 20,00 | 679 | 13.580 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 28.08.2026 | Optionsausübung | 8,04 | 679 | 5.459 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 18.08.2026 | Verkauf | 20,05 | 31.031 | 622.324 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 18.08.2026 | Optionsausübung | 9,88 | 31.031 | 306.586 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 17.08.2026 | Verkauf | 20,00 | 1.000 | 20.000 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 17.08.2026 | Optionsausübung | 12,65 | 1.000 | 12.650 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 17.08.2026 | Verkauf | 19,94 | 3.749 | 74.762 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 17.08.2026 | Verkauf | 19,85 | 37.945 | 753.333 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 17.08.2026 | Optionsausübung | 9,88 | 2.876 | 28.415 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 17.08.2026 | Optionsausübung | 9,88 | 37.945 | 374.897 | Form 4 |
| AVTX | Riley Jennifer | Chief Strategy Officer | 11.08.2026 | Verkauf | 19,59 | 2.655 | 52.012 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 10.08.2026 | Verkauf | 20,00 | 679 | 13.580 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 10.08.2026 | Optionsausübung | 8,04 | 679 | 5.459 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 27.07.2026 | Verkauf | 20,00 | 1.000 | 20.000 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 27.07.2026 | Optionsausübung | 12,65 | 1.000 | 12.650 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).